Brief: Promore Pharma Unit Pergamum Gets Patent For PXL01 In Us
Nov 12 (Reuters) - Promore Pharma AB PROMO.ST :
* PROMORE PHARMA IS GRANTED A PATENT FOR PXL01 IN THE US
* SUBSIDIARY PERGAMUM AB WAS GRANTED A PATENT IN US FOR
PHARMACEUTICAL FORMULATION OF PRODUCT CANDIDATE PXL01
* PATENT IS VALID AT LEAST UNTIL JANUARY 2030
Source text for Eikon: ID:nWkr6rKcrM
Further company coverage: PROMO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PMD Device Solutions AB
See all newsBrief: PMD Device Solutions Files For Bankruptcy
Brief: PMD Device Solutions Q3 EBITDA Loss Widens To SEK 8.9 Mln
Brief: Pmd Device Solutions Completes Sale Of Coala Life Monitor
Brief: PMDS’ Largest Shareholder Requests EGM To Appoint New Non-Executive Directors
Brief: PMDS Says RespiraSense Technology Demonstrates Capability In Predicting 7-Day Mortality